Oppenheimer Hires Joel Sendek As Head of Healthcare Life Sciences Research Team, Further Bolstering the Firm's Commitment to an Important Area of Focus

Stock Information for Oppenheimer Holdings Inc. Class A (DE)

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Oppenheimer Holdings Inc. Class A (DE)

Oppenheimer Holdings Inc. Reports Second Quarter 2024 Earnings
Oppenheimer Announces Additions to the High Yield and Distressed Debt Team
Oppenheimer & Co. Inc. Appoints Andreas Argyrides As Executive Director and Senior Analyst Covering the Biotechnology Sector
Oppenheimer & Co. Inc. Appoints Rayna Kumar As Managing Director and Senior Analyst Covering the Fintech Sector
Oppenheimer Hires Kunal Bhatia As Managing Director, Healthcare Investment Banking
Oppenheimer Expands Its Global Investment Banking Capabilities with the Addition of Martin Chamberlin
Oppenheimer Expands Technology Investment Banking Group with Addition of Yogesh Amle
Oppenheimer Expands Its Investment Banking Capabilities with the Hires of Dmitry Gladkov and Konstantin Derkatschew

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.